Arimoclomol Citrate Patent Expiration
Arimoclomol Citrate was first introduced by Zevra Denmark As
Arimoclomol Citrate Patents
Given below is the list of patents protecting Arimoclomol Citrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Miplyffa | US11045460 | Use of Hsp70 as a regulator of enzymatic activity | Aug 19, 2029 | Zevra Denmark |
| Miplyffa | US9289472 | Use of HSP70 as a regulator of enzymatic activity | Aug 11, 2029 | Zevra Denmark |
| Miplyffa | US9884058 | Use of Hsp70 as a regulator of enzymatic activity | Jun 26, 2029 | Zevra Denmark |
Arimoclomol Citrate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List